These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7233399)

  • 1. Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin.
    Carter CJ; Kelton JG; Hirsh J; Gent M
    Thromb Res; 1981 Jan 1-15; 21(1-2):169-74. PubMed ID: 7233399
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative comparison of recombinant hirudin's antithrombotic and anticoagulant activities with those of heparin.
    Porta R; Pescador R; Mantovani M; Prino G
    Thromb Res; 1990 Feb; 57(4):639-43. PubMed ID: 2326777
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits.
    Carter CJ; Kelton JG; Hirsh J; Cerskus A; Santos AV; Gent M
    Blood; 1982 Jun; 59(6):1239-45. PubMed ID: 7082826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Characterization of a Heparin-Like Compound with Potent Anticoagulant and Fibrinolytic Activity from the Clam
    Du Z; Jia X; Chen J; Zhou S; Chen J; Liu X; Cao X; Zhong S; Hong P
    Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31861572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic activity and its relationship to in vitro anticoagulant effects.
    Gray E; Padilla A; Barrowcliffe TW
    Haemostasis; 1993 Mar; 23 Suppl 1():99-102. PubMed ID: 8388358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant and antithrombotic actions of a semisynthetic beta-1,3-glucan sulfate.
    Alban S; Jeske W; Welzel D; Franz G; Fareed J
    Thromb Res; 1995 May; 78(3):201-10. PubMed ID: 7631300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant and antithrombotic properties of synthetic sulfated bis-lactobionic acid amides.
    Raake W; Klauser RJ; Elling H; Meinetsberger E
    Thromb Res; 1989 Dec; 56(6):719-30. PubMed ID: 2561233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological actions of sulodexide.
    Ofosu FA
    Semin Thromb Hemost; 1998; 24(2):127-38. PubMed ID: 9579633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulant, fibrinolytic and antithrombotic effects of the heparin-insulin complex].
    Liapina LA; Pastorova VE
    Izv Akad Nauk Ser Biol; 2002; (6):710-3. PubMed ID: 12561334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
    Hamano S; Nishiyama M; Kikuchi S; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
    Thromb Res; 1992 May; 66(4):299-307. PubMed ID: 1329257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
    Kaiser B; Hauptmann J; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis.
    Elg M; Gustafsson D; Deinum J
    Thromb Haemost; 1997 Oct; 78(4):1286-92. PubMed ID: 9364999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of the anticoagulant effect of heparin in vitro.
    Bjornsson TD; Wolfram KM
    Ann N Y Acad Sci; 1981; 370():656-61. PubMed ID: 6168226
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic and anticoagulant properties of synthetic polyanions: sulfated bis-aldonic acid amides.
    Klauser RJ; Raake W; Meinetsberger E; Zeiller P
    J Pharmacol Exp Ther; 1991 Oct; 259(1):8-14. PubMed ID: 1656031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antithrombotic effects of low molecular weight heparinoid KB-101 and heparin in a rat experimental model.
    Suehiro A; Imaoka J; Kakishita E
    Gen Pharmacol; 1993 Mar; 24(2):341-4. PubMed ID: 8387051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacology of aprosulate, a new synthetic polyanion with anticoagulant activity.
    Sugidachi A; Asai F; Koike H
    Thromb Res; 1993 Jan; 69(1):71-80. PubMed ID: 8465276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant and antithrombotic activities of a chemically sulfated galactoglucomannan obtained from the lichen Cladonia ibitipocae.
    Martinichen-Herrero JC; Carbonero ER; Sassaki GL; Gorin PA; Iacomini M
    Int J Biol Macromol; 2005 Mar; 35(1-2):97-102. PubMed ID: 15769521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
    Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.